A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis
Clinical trial NCT02627768 · COMPLETED
Trial details
- NCT number
- NCT02627768
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-12-17
- Primary completion
- 2020-12-31
- Enrollment
- 991
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.